SCHEMBL24760933

SCHEMBL24760933

CC(C)c1nc(N)sc1-c1ccnc(S(C)(=O)=O)n1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK2 P24941 7/20 0.34
CDK4 P11802 6/20 0.34
PLK1 P53350 1/20 0.34
CCNE1 P24864 4/20 0.34
DYRK1A Q13627 2/20 0.33
DYRK2 Q92630 1/20 0.33
DYRK1B Q9Y463 1/20 0.33
BRAF P15056 2/20 0.32
CDK9 P50750 4/20 0.32
CCNT1 O60563 3/20 0.32
AURKA O14965 3/20 0.32
AURKB Q96GD4 3/20 0.32
ABL1 P00519 2/20 0.32
CDK1 P06493 2/20 0.32
CCNA2 P20248 2/20 0.32
GSK3B P49841 2/20 0.32
CDK5 Q00535 2/20 0.32
CDK7 P50613 2/20 0.32
CCNB2 O95067 1/20 0.32
CCNE2 O96020 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24761207 0.78 CDK4 (0.37) CDK2CDK4PLK1CCNE1DYRK1A
SCHEMBL29796659 0.78 CDK4 (0.42) CDK2CDK4PLK1CCNE1DYRK1A
SCHEMBL24760759 0.77 CDK2 (0.44) CDK2CDK4PLK1CCNE1DYRK1A
SCHEMBL24760928 0.76 LMNA (0.44) CDK2CDK4PLK1CCNE1DYRK1A
SCHEMBL6842494 0.74 ALDH1A1 (0.52) BRAFTGFBR1EGFRJAK3MAPK10
SCHEMBL6840084 0.72 KDM4B (0.46) MKNK2
SCHEMBL26097473 0.72 TGFBR1 (0.48) TGFBR1PIK3CDPI4KAPIK3CGPI4KB
SCHEMBL3568782 0.71 CDK2 (0.59) CDK2CDK4PLK1CCNE1CDK9
SCHEMBL6835784 0.70 KDM4E (0.32) DYRK1ADYRK2DYRK1BBRAFPIK3CD
SCHEMBL2460112 0.69 DYRK1B (0.34) CDK2CCNE1DYRK1ADYRK2DYRK1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022157166-A1 THIAZOLOPYRIMIDONES AS INHIBITORS OF DDR1/2 AND THERAPEUTIC USES THEREOF Fundación Del Sector Público Estatal Centro Nacional De Investigaciones Oncológicas Carlos III (F.S.P. CNIO) (ES) 2022-07-28 WO disclosed
EP-4032896-A1 THIAZOLOPYRIMIDONES AS INHIBITORS OF DDR1/2 AND THERAPEUTIC USES THEREOF Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III (F.S.P. CNIO) (ES) 2022-07-27 EP disclosed